Back in January of 2013 Mirna Therapeutics announced the new appointment of Clay Siegall, Ph.D. to their Board of Directors. According to Dr. Paul Lammers, the President, and Chief Executive Office of Mirna, the Mirna company is very excited to have had Siegall to their distinguished group of directors. With his broad pharmaceutical industry experience, as well as his successful oncology company Clay will make an invaluable addition to the board. It is widely thought that Clay will help Mirna be able to make further advancements in the development of their microRNA therapeutics.
Clay Siegall attended the University of Maryland and graduated with a Bachelor of Science in Zoology. He then later went on to his Doctor of Philosophy in Genetics from George Washington University.
In 1998, he co-founded Seattle Genetics and still functions as the company’s President, Chief Executive Officer and Chairman of the Board. Clay was able to build his company to be a great foundation of scientific innovation, while providing great research, and is able to participate in many drug development practices.
Mirna Therapeutics is a biotechnology company that has been focusing on the development and commercialization of microRNA therapies since 2007. These therapies are a new and still exciting area of cancer research. The company is located in Austin, Texas and has received the majority of its funding from private investors and has even received some funding from the State of Texas.
MicroRNAs, also known as miRNAs, are made up of 20 to 25 nucleotides and affect gene expression by communicating with messenger RNA. miRNAs are a part of the human genome and are used as natural regulators of gene expression. There are more than 1,400 miRNAs in the human genome and they are each able to regulate the expression of tens to hundreds different genes. This means that they are able to regulate and coordinate many cellular pathways and processes. With so much power, miRNAs are able to guide proper embryonic development, inflammation, immunity, and cell growth. Misregulations that sometimes take place, plays a role in the growth and dissemination of many types of cancers.